Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael H Tardugno is Executive Chairman of Board at Imunon. OQRO lists 15 transactions filed with the SEC under this name, the latest on Nov 11, 2026, each linked to the official Form 4.
Executive Chairman of Board
Disclosures on record
15
Companies involved
1
Michael H Tardugno bought shares on the open market in 14 different years since 2007, and has not bought since 2024.
Michael H Tardugno reported 37 open-market purchases and 0 sales since 2007; purchases in 14 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $26K1×1 trade | — |
| 2022 | $14K1×1 trade | — |
| 2019 | $11K1×1 trade | — |
| 2018 | $39K3×3 trades | — |
| 2016 | $47K7×7 trades | — |
| 2015 | $11K1×1 trade | — |
| 2014 | $44K3×3 trades | — |
| 2013 | $29K3×3 trades | — |
| 2012 | $25K2×2 trades | — |
| 2011 | $59K4×4 trades | — |
| 2010 | $16K1×1 trade | — |
| 2009 | $45K3×3 trades | — |
| 2008 | $19K4×4 trades | — |
| 2007 | $38K3×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
ImunonIMNN
15 disclosures · Jan 2026 – Nov 2026
Nov 6, 20269,969disclosed Nov 11
DetailsOfficial recordOct 23, 20266,821disclosed Oct 27
DetailsOfficial recordOct 9, 20267,800disclosed Oct 13
DetailsOfficial recordSep 25, 20267,169disclosed Sep 28
DetailsOfficial recordSep 11, 20265,824disclosed Sep 15
DetailsOfficial recordAug 28, 20267,371disclosed Sep 1
DetailsOfficial recordAug 14, 20267,147disclosed Aug 17
DetailsOfficial recordJul 31, 20266,358disclosed Aug 4
DetailsOfficial recordJul 17, 20264,603disclosed Jul 21
DetailsOfficial recordJul 2, 20264,410disclosed Jul 7
DetailsOfficial recordJun 25, 202643Kdisclosed Jun 29
DetailsOfficial recordJun 18, 20264,629disclosed Jun 23
DetailsOfficial recordJun 5, 20264,089disclosed Jun 9
DetailsOfficial recordMay 22, 20263,484disclosed May 27
DetailsOfficial recordJan 2, 202644Kdisclosed Jan 6
DetailsOfficial recordAs of the latest filing on , Michael H Tardugno reported holding 128,511 shares of Imunon (IMNN), worth about $81K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Imunon IMNN | 128,511 | 129K direct | $1 | $81K | Nov 6, 2026 |
Is this Michael H Tardugno’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 6, 2026, Michael H Tardugno reported holding 128,511 shares of Imunon (IMNN). At the last close of $1 on Nov 13, 2026, that is about $81K. This is the stake disclosed in filings, not a net worth.
Michael H Tardugno bought shares on the open market in 14 different years since 2007, and has not bought since 2024.
In SEC filings since 2007: the latest open-market purchase is from 2024; no open-market sale is on record.
Imunon (IMNN), from 2007 to 2024: 37 purchases and 0 sales.
Michael H Tardugno reported 37 open-market purchases and 0 sales here, 2007 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.